Consumerism to Be the Top Priority in Cloudbased Drug Discovery Platform Market

The Cloudbased Drug Discovery Platform Market is bound to grow robustly in the years to come. With smart technology and 5G being increasingly adopted, the healthcare vertical is witnessing a paradigm shift. These technologies can thus increase the convenience quotient (CQ), as abysmal disruption happens in the patients' lives. This convenience quotient would be the trend running in the healthcare vertical shortly.

A new report by Persistence Market Research presents interesting facets of the global cloud-based drug discovery platform market and provides value forecasts for an eight year period from 2017 to 2025. The report titled 'Cloud-based Drug Discovery Platform Market: Global Industry Analysis (2012 - 2016) and Forecast (2017-2025)' is a comprehensive take on the global cloud-based drug discovery platform market and highlights the different factors anticipated to impact market revenue growth during the said period.

According to Persistence Market Research estimations, the global cloud-based drug discovery platform market is projected to be valued at US$ 1,601.1 Mn by the end of 2017 and is expected to reach a market valuation of US$ 4,323.5 Mn by the end of the forecast period in 2025, witnessing a CAGR of 13.2% in terms of value during the forecast period.

Strategizing The Moves For The Next Decade? See Through Sample Of Cloudbased Drug Discovery Platform Market Report! https://www.persistencemarketresearch.com/samples/11020

Company Profiles:

IBM Corporation
Tata Consultancy Services Limited
SAS Institute Inc.
BioXcel Corporation
Cloud Pharmaceuticals Inc.
WuXi AppTec (Sanghai) Co. Ltd.
Dassault System
Acelot, Inc.
Get A Customized Scope To Match Your Need Ask An Expert - sales@persistencemarketresearch.com

cloud based drug discovery platform market

Starting With The New Decade On A Diligent Note In The Cloud-based Drug Discovery Platform Market? https://www.persistencemarketresearch.com/methodology/11020

Global Cloud-based Drug Discovery Platform Market: Dynamics

Revenue drivers

Increasing adoption of cloud-based platforms in the healthcare industry to enhance research efficiency.

Traction in the adoption of machine learning and artificial intelligence for drug discovery.

Regional healthcare companies adopting cloud-based technologies for collaboration with international healthcare market players.

Growth challenges

Concerns regarding infrastructure compatibility issues.

Issues pertaining to interoperability of applications with devices.

Market trends

Upsurge in the implementation of cloud-based platforms in the healthcare sector across the North American region.

Rising adoption of cloud-based mobile applications for collaborative drug discovery.

Global Cloud-based Drug Discovery Platform Market: Forecast by End User

The global cloud-based drug discovery platform market is segmented on the basis of end-user into Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations, and Others.

Pharmaceutical Vendors is expected to be the largest segment in terms of revenue, with a CAGR of 13.4%. Biotech Vendors is the second largest segment in terms of value, estimated to reach a market valuation of US$ 1,247.8 Mn by the end of 2025.

How About Obtaining Insights About The Region To Enter Concerning The Cloudbased Drug Discovery Platform Market? Press The "Purchase Now" Button To Have Our Cloudbased Drug Discovery Platform Market Report! https://www.persistencemarketresearch.com/checkout/11020

Global Cloud-based Drug Discovery Platform Market: Forecast by Region

Persistence Market Research tracks the performance of the global cloud-based drug discovery platform market across the key regions of North America, Latin America, Europe, Asia Pacific, and MEA. In terms of value, North America is projected to be the most attractive market in the global cloud-based drug discovery platform market during the forecast period.

The North America regional market for cloud-based drug discovery platforms is estimated to hold more than 35% value share by the end of the forecast period in 2025. However, the market in APAC is expected to register high Y-o-Y growth rates throughout the forecast period. In terms of value, the APAC cloud-based drug discovery platform market is expected to expand at a CAGR of 16.7% during the forecast period.

Access Related Reports-

Mobile Operating Tables Market: https://www.persistencemarketresearch.com/market-research/mobile-operating-tables-market.asp

Cmo Cdmo Biotechnology Market: https://www.persistencemarketresearch.com/market-research/cmo-cdmo-biotechnology-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.